Stock of Covishield is 99000 doses
Due to the paucity of Oxford-AstraZeneca (Covishield) corona vaccine in stock in the country, the second dose cannot be given to 100% of the first dose recipients.
One crore 1 lakh 791 doses of vaccine have been given till date after the start of vaccination program in the country. The total has been given by the Covishield vaccine made by the Seram Institute of India in the Oxford-AstraZeneca formula. So far, 1 crore 2 lakh doses of vaccine have arrived in the country. Accordingly, only 99,209 doses of vaccine are in stock.
The information came from a press release issued by the Directorate of Health on Thursday (June 24).
According to the Department of Health, 58 lakh 20 thousand 15 people have taken the first dose of the vaccine so far. And the second dose was taken by 42 lakh 81 thousand 776 people. In other words, one crore 1 lakh 791 doses of vaccine have been given in two doses.
According to the Directorate of Health, out of 58 lakh 20 thousand 15 people who took the first dose, more than 14 lakh people facing crisis for the second dose. All of them need to be given the second dose of the Oxford AstraZeneca vaccine. This is because the World Health Organization has not yet made any decision on using two does of two companies.
The national corona vaccination program started on February 7 in the country. This activity ran every day from 8:30 am to 2:30 pm. The second dose vaccination program started on April 8.
The coronavirus vaccine is being administered in the country through the Covshield vaccine developed by the Serum Institute of India, invented by Oxford-AstraZeneca. The government of Bangladesh has signed an agreement with Seram for three crore dose vaccines. Although 50 lakh doses of vaccine are supposed to come from there every month, so far one crore and two lakh doses have been received.